Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Gunnar Söderqvist. (1998) Effects of sex steroids on proliferation in normal mammary tissue. Annals of Medicine 30:6, pages 511-524.
Read now
Read now
Sylvie Bardon, Karine Picard & Paule Martel. (1998) Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines. Nutrition and Cancer 32:1, pages 1-7.
Read now
Read now
Articles from other publishers (21)
Yanamandala Nitheesh, Rajesh Pradhan, Siddhant Hejmady, Rajeev Taliyan, Gautam Singhvi, Amit Alexander, Prashant Kesharwani & Sunil Kumar Dubey. (2021) Surface engineered nanocarriers for the management of breast cancer. Materials Science and Engineering: C 130, pages 112441.
Crossref
Crossref
Yuan‑Yuan Pei, Gao‑Chi Li, Jian Ran & Feng‑Xiang Wei. (2017) Kinesin family member 11 contributes to the progression and prognosis of human breast cancer. Oncology Letters.
Crossref
Crossref
Zoi Lanara, Efstathia Giannopoulou, Marta Fullen, Evangelos Kostantinopoulos, Jean-Christophe Nebel, Haralabos P Kalofonos, George P Patrinos & Cristiana Pavlidis. (2013) Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection. Human Genomics 7:1.
Crossref
Crossref
Nara Macedo Botelho Brito, Rita de Kássia Vidigal Carvalho, Lia Tavares de Moura Brasil Matos, Rodolfo Costa Lobato & Rosângela Baía Brito. (2009) The oophorectomy effect on Walker 256 tumor inoculated into the vagina and uterine cervix of female rats. Acta Cirurgica Brasileira 24:1, pages 26-29.
Crossref
Crossref
Jingbo Liu, Jing Li & Neil Sidell. (2006) Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells. Cancer Chemotherapy and Pharmacology 59:2, pages 217-225.
Crossref
Crossref
Tracey M. Rowlands, Irina V. Pechenkina, Sarah J. Hatsell, Richard G. Pestell & Pamela Cowin. (2003) Dissecting the roles of β-catenin and cyclin D1 during mammary development and neoplasia. Proceedings of the National Academy of Sciences 100:20, pages 11400-11405.
Crossref
Crossref
Julia Gee & Robert Nicholson. 2002. Breast Cancer. Breast Cancer
301
342
.
Haiyan Pang & Lee E. Faber. (2001) Estrogen and rapamycin effects on cell cycle progression in T47D breast cancer cells. Breast Cancer Research and Treatment 70:1, pages 21-26.
Crossref
Crossref
Sayan Sawatsri, Dvorit Samid, Srividya Malkapuram & Neil Sidell. (2001) Inhibition of estrogen-dependent breast cell responses with phenylacetate. International Journal of Cancer 93:5, pages 687-692.
Crossref
Crossref
Ya-Hua Zhuang, Dana Sarca, Alessandro Weisz, Lucia Altucci, Luigi Cicatiello, Eva Rollerova, Pentti Tuohimaa & Timo Ylikomi. (2001) Cell type-specific induction of cyclin D and cyclin-dependent kinase inhibitor p27kip1 expression by estrogen in rat endometrium. The Journal of Steroid Biochemistry and Molecular Biology 78:2, pages 193-199.
Crossref
Crossref
Esther Hulleman, Jose J.M. Bijvelt, Arie J. Verkleij, C.Theo Verrips & Johannes Boonstra. (1999) Integrin Signaling at the M/G1 Transition Induces Expression of Cyclin E. Experimental Cell Research 253:2, pages 422-431.
Crossref
Crossref
Sheng Wang, Niharika Nath, Matthew Adlam & Srikumar Chellappan. (1999) Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 18:23, pages 3501-3510.
Crossref
Crossref
Jianli Sang & Yongchao Wang. (1999) Effects ofPKCα antisense RNA on human breast cancer cell proliferation and expression ofcyclinD1 andCDK4. Chinese Science Bulletin 44:12, pages 1110-1114.
Crossref
Crossref
Paola Collecchi,Anna Passoni, Marina Rocchetta, Elisa Gnesi, Editta Baldini & Generoso Bevilacqua. (1999) Cyclin-D1 expression in node-positive (N+) and node-negative (N?) infiltrating human mammary carcinomas. International Journal of Cancer 84:2, pages 139-144.
Crossref
Crossref
J. S. de Jong, P. J. van Diest, R. J. Michalides & J. P. Baak. (1999) Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas. Molecular Pathology 52:2, pages 78-83.
Crossref
Crossref
Michel Oettel & Ekkehard SchillingerG. Söderqvist & B. Von Schoultz. 1999. Estrogens and Antiestrogens II. Estrogens and Antiestrogens II
113
128
.
Maria Luisa Veronese, Florencia Bullrich & Carlo M. Croce. 1999. Endocrinology of Breast Cancer. Endocrinology of Breast Cancer
93
108
.
Sally D. Worsley, Bruce A.J. Ponder & Barry R. Davies. (1997) Overexpression of Cyclin D1 in Epithelial Ovarian Cancers. Gynecologic Oncology 64:2, pages 189-195.
Crossref
Crossref
Gunnar Söderqvist, Erika Isaksson, Bo von Schoultz, Kjell Carlström, Edneia Tani & Lambert Skoog. (1997) Proliferation of breast epithelial cells in healthy women during the menstrual cycle. American Journal of Obstetrics and Gynecology 176:1, pages 123-128.
Crossref
Crossref
T. K. Said, S. Bonnette & D. Medina. (2008) Immortal, non‐tumourigenic mouse mammary outgrowths express high levels of cyclin B1 and activation of cyclin B1/cdc2 kinase. Cell Proliferation 29:11, pages 623-639.
Crossref
Crossref
P. Pelosio, M. Barbareschi, E. Bonoldi, A. Marchetti, P. Verderio, O. Caffo, P. Bevilacqua, P. Boracchi, F. Buttitta, R. Barbazza, P. Dalla Palma & G. Gasparini. (1996) Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. Annals of Oncology 7:7, pages 695-703.
Crossref
Crossref